Product specialist
Roche
Total years of experience :18 years, 8 Months
• Brands: Herceptin® ( Trustuzumab).
• Disease Area: HER2+ Breast Cancer and Gastric Cancer.
• Reporting to: Western Zone Sales Manager .
• Promoting Herceptin® crossover Western Zone, KSA.
• Includes managing target of prescriptions, prescribers and patients.
• Management of the KOLs.
• Reporting all adverse events to medical department ‘safety profile’.
• Pre planning for the activities and estimating the cost on monthly and annual basis.
• Gathering market intelligence data about the competitors’ activities and customer
• Satisfaction and communicating them in time and with proper communication tool.
• Forecasting of the anticipated sales and prescriptions in my territory.
• Branding Roche as an Oncology Specialized company
• Achievements:
➢ Market leader in Breast Cancer HER+2.
➢ Handling FISH test program, kingdom of Saudi Arabia
• Brands: Betaferon® ( interferon beta-1-b).
• Disease Area: MS (Multiple Sclerosis).
• Reporting to: Egypt Area Field Supervisor & Product Manager.
• Promoting Betaferon® crossover the Delta and Cairo zone in Egypt.
• Includes managing target of prescriptions, prescribers and patients.
• Management of the KOLs.
• Pre planning for the activities and estimating the cost on monthly and annual basis.
• Gathering market intelligence data about the competitors’ activities and customer
Satisfaction and communicating them in time and with proper communication tool.
• Forecasting of the anticipated sales and prescriptions in my territory.
• Awareness campaign for MS patients .
• Brands: Nexavar®, Zevalin®, Campath®, Fludara®, Bonefos® .
• Disease Area: Hepatocellular Carcinoma, Renal Cell Carcinoma, NHL, CLL Cancer.
• Reporting to: Egypt Area Field Supervisor, Product Manager & Sales Manager .
• Promoting Oncology / Hematology portfolio crossover the Delta and Cairo Zone in Egypt.
• Includes managing target of prescriptions, prescribers and patients.
• Management of the KOLs.
• Pre planning for the activities and estimating the cost on weekly, monthly and annual basis.
• Gathering market intelligence data about the competitors’ activities and customer
• Satisfaction and communicating them in time and with proper communication tool.
• Forecasting of the anticipated sales and prescriptions in my territory.
• Launching and establishing Nexavar® (Sorafenib) in Egypt.
• Establish Nexavar business, shifting doctors’ treatment mindset from “dying”(non-treated) patients into “treatable” patients.
• Implementation of the multidisciplinary approach; overcome the defective practice of both oncologists and hepatologists, ending with new-minded treating teams.
• Achievements:
➢ Successful launch of Nexavar in Egypt for both RCC and HCC indications.
➢ KOL management program implementation.
➢ Strong positioning of Nexavar in RCC across the Oncologists & Uro-oncologists to enforce using it as first line therapy.
➢ Positioning Nexavar in HCC across the Oncologists and Hepatologists to enforce using it with the already “non-treatable” patients.
• Area : Delta zone and Cairo.
• Brands: (Avalox®, Ciprobay®, Glucobay®, Mycospor®, Becozym®, Renni®, Bepanthen®)
• Monitor market conditions, product innovations, and competitors' products, prices, and sales
Master International Business Administration (MBA) Dual Coré : Marketing & Management ESLSCA Ecole Supérieure Libre de Sciences Commerciales Appliquées - Paris